Free Trial
NASDAQ:ATNF

180 Life Sciences (ATNF) Stock Price, News & Analysis

180 Life Sciences logo
$3.10 +0.03 (+0.81%)
As of 08/26/2025

About 180 Life Sciences Stock (NASDAQ:ATNF)

Key Stats

Today's Range
$3.05
$3.23
50-Day Range
$0.80
$10.70
52-Week Range
$0.66
$17.75
Volume
13.80 million shs
Average Volume
22.03 million shs
Market Capitalization
$18.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

180 Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
10th Percentile Overall Score

ATNF MarketRank™: 

180 Life Sciences scored higher than 10% of companies evaluated by MarketBeat, and ranked 914th out of 945 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for 180 Life Sciences.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 180 Life Sciences is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 180 Life Sciences is -0.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    180 Life Sciences has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about 180 Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    30.55% of the float of 180 Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    180 Life Sciences has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 180 Life Sciences has recently increased by 1,681.25%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    180 Life Sciences does not currently pay a dividend.

  • Dividend Growth

    180 Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    30.55% of the float of 180 Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    180 Life Sciences has a short interest ratio ("days to cover") of 0.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in 180 Life Sciences has recently increased by 1,681.25%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    180 Life Sciences has a news sentiment score of 0.93. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for 180 Life Sciences this week, compared to 0 articles on an average week.
  • Search Interest

    22 people have searched for ATNF on MarketBeat in the last 30 days. This is an increase of 214% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added 180 Life Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, 180 Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    38.20% of the stock of 180 Life Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 4.07% of the stock of 180 Life Sciences is held by institutions.

  • Read more about 180 Life Sciences' insider trading history.
Receive ATNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 180 Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATNF Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.tc pixel
AMD, KinderCare, 180 Life Sciences: Trending Tickers
See More Headlines

ATNF Stock Analysis - Frequently Asked Questions

180 Life Sciences' stock was trading at $1.82 at the beginning of 2025. Since then, ATNF stock has increased by 70.3% and is now trading at $3.10.

180 Life Sciences Corp. (NASDAQ:ATNF) issued its quarterly earnings results on Wednesday, July, 23rd. The company reported ($0.30) EPS for the quarter.

Shares of 180 Life Sciences reverse split on the morning of Wednesday, February 28th 2024.The 1-19 reverse split was announced on Wednesday, February 28th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, February 28th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of ATNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that 180 Life Sciences investors own include Meta Platforms (META), NIO (NIO), Enterprise Products Partners (EPD), HubSpot (HUBS), Netflix (NFLX), Plug Power (PLUG).

Company Calendar

Last Earnings
7/23/2025
Today
8/27/2025
Next Earnings (Estimated)
11/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATNF
Previous Symbol
NASDAQ:KBLM
CIK
1690080
Fax
N/A
Employees
7
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($15.07)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$6.17 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-141.25%
Return on Assets
-80.77%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.58
Quick Ratio
0.58

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.91 per share
Price / Book
1.07

Miscellaneous

Outstanding Shares
6,039,000
Free Float
3,732,000
Market Cap
$18.72 million
Optionable
No Data
Beta
0.38
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:ATNF) was last updated on 8/27/2025 by MarketBeat.com Staff
From Our Partners